The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 06, 2026 for Aayush Agrawal, ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Midcap 150 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ajanta Pharma promoter Aayush Agrawal (trustee of Aayush Agrawal Trust) released a pledge on 1,49,000 shares (0.12% of total share capital) on 4 February 2026. The pledge was held with RBL Bank Limited, and the reason cited is a reduction in the bank guarantee amount. After this release, the trust's encumbered shares stand at 80,99,407 shares (6.48%), down from 82,48,407 shares (6.60%) earlier. The trust's overall promoter holding remains at 1,41,12,924 shares (11.30%) of the company.
This is a routine, small pledge release (less than 0.15% of share capital) due to a bank guarantee reduction, not a stress signal. Shareholders are unlikely to see any meaningful impact on the stock price from this disclosure.